{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001039407.1:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_001039407.1",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "p.G2019S (LRRK2 variant associated with Parkinson's disease)"
        }
      ]
    },
    {
      "Gene": "GBA",
      "variants": [
        {
          "HGVS": "NM_000364.3:c.1093A>T",
          "cDNA Change": {
            "transcript": "NM_000364.3",
            "ref": "A",
            "alt": "T",
            "position": "1093"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "S",
            "position": "370"
          },
          "Description in input context": "p.N370S (GBA variant associated with Gaucher disease)"
        }
      ]
    },
    {
      "Gene": "SOD1",
      "variants": [
        {
          "HGVS": "NM_000341.2:c.119C>T",
          "cDNA Change": {
            "transcript": "NM_000341.2",
            "ref": "C",
            "alt": "T",
            "position": "119"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "40"
          },
          "Description in input context": "p.A4T (SOD1 variant associated with Amyotrophic Lateral Sclerosis)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease, Gaucher disease, Amyotrophic Lateral Sclerosis",
    "MONDO": "MONDO:0005346, MONDO:0008719, MONDO:0000127"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with wild-type and variant LRRK2 constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039407.1:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 p.G2019S exhibited increased kinase activity compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA with post-hoc Tukey's test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 10% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity exceeding 30% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Postmortem brain tissue from Gaucher disease patients",
        "Description": "Tissue samples were analyzed for GBA p.N370S accumulation."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000364.3:c.1093A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "GBA p.N370S showed reduced enzyme activity and increased glucosylceramide accumulation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Five tissue samples from Gaucher disease patients were analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each slide was analyzed in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type GBA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative控制": "No",
        "Description": "Control samples were not explicitly mentioned."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "4"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Description": "No benign variant controls were reported."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Student's t-test comparing mutant vs. wild-type samples."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Glucosylceramide levels within 20% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Glucosylceramide levels exceeding 50% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Luciferase Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "NSC-34 motor neuron cells",
        "Description": "Cells were transfected with SOD1 variants and luciferase reporter constructs."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000341.2:c.119C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "toxic gain-of-function",
          "Result Description": "SOD1 p.A4T induced increased oxidative stress and neuronal death compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four independent biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was analyzed in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type SOD1 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "3"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "2"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Mann-Whitney U test comparing mutant vs. wild-type samples."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Oxidative stress levels within 15% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Oxidative stress levels exceeding 40% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}